MeSH term
Frequency | Condition_Probility | Adult | 5 | 0.0 |
Exons | 5 | 0.0 |
Female | 8 | 0.0 |
Humans | 18 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 2 | 0.0 |
Oxidoreductases/*genetics | 8 | 8.0 |
*Oxidoreductases Acting on CH-CH Group Donors | 16 | 17.0 |
*Point Mutation | 2 | 0.0 |
Porphyrias, Hepatic/*genetics | 3 | 60.0 |
Research Support, Non-U.S. Gov't | 18 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
Gene Expression/genetics | 3 | 1.0 |
Introns | 3 | 0.0 |
Oxidoreductases/*genetics/metabolism | 2 | 10.0 |
South Africa | 4 | 2.0 |
Transfection | 2 | 0.0 |
Escherichia coli/enzymology/genetics | 2 | 3.0 |
Genetic Complementation Test | 3 | 0.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
*Alleles | 2 | 0.0 |
European Continental Ancestry Group/genetics | 4 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Animals | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
*Mutation | 3 | 0.0 |
Mutation, Missense | 3 | 0.0 |
Pedigree | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Porphyrias, Hepatic/diagnosis/*genetics | 2 | 100.0 |
Restriction Mapping | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Base Sequence | 6 | 0.0 |
Child | 2 | 0.0 |
Genotype | 2 | 0.0 |
Heteroduplex Analysis | 2 | 2.0 |
Mutation | 7 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Adolescent | 2 | 0.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Ferrochelatase/genetics | 2 | 50.0 |
Hydroxymethylbilane Synthase/genetics | 2 | 12.0 |
Sequence Alignment | 2 | 0.0 |
